Cellino
Suvi Aivio is the current head of biology at Cellino. Suvi has previous experience as a stem cell scientist and head of biology at the company. Suvi also has experience as a postdoctoral research fellow at Harvard Medical School and Brigham and Women's Hospital, where they researched human iPS cell culture and differentiation into skeletal muscle, as well as CRISPR design and cloning. Prior to that, they were a researcher at the Institute for Research in Biomedicine in Barcelona, where they researched genomic instability and cancer, mitochondria, metabolism, and aging. Suvi also has experience as a research assistant at UCLA, where they researched hematopoietic stem cell differentiation and human embryonic stem cells. Finally, they were a research assistant and Master's Thesis student at BioMediTech - institute of biosciences and medical technology, where they researched human embryonic stem cells and optimized xeno-free growth conditions.
Suvi Aivio has a Ph.D. from Universitat Pompeu Fabra in Biomedicine, which they obtained in 2014. Suvi also has a Master's degree in Biochemistry from the University of Jyväskylä, which they obtained in 2007. Between their undergraduate and graduate studies, they worked as a pharmaceutical sales representative for Capsil ltd.
Mariangela Amenduni, Kien Tran, Stefanie Morgan, and Deniz Aksel all work with Suvi Aivio in some capacity. Mariangela Amenduni is a Senior Stem Cell Scientist, Kien Tran is a Stem Cell Scientist, Stefanie Morgan is an Associate Director of Molecular Biology, and Deniz Aksel is a Senior Bioengineer.
This person is not in any teams
This person is not in any offices
Cellino
Cellino is an autologous regenerative medicine company developing an AI-guided single-cell laser editing platform for cell-based therapies. The company has developed a scalable platform that automates and standardizes autologous stem cell production, accelerating the development of life-saving medicines for patients. Cellino is based in Cambridge, MA.